Stock MPL MEDIBANK PRIVATE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Medibank Private Limited

Equities

MPL

AU000000MPL3

Market Closed - Australian S.E.
Other stock markets
 02:10:45 2024-05-10 am EDT 		5-day change 1st Jan Change
3.65 AUD +0.27% Intraday chart for Medibank Private Limited +6.10% +2.53%
May. 08 Jarden Adjusts Medibank Private Price Target to AU$3.85 from AU$3.80, Keeps at Neutral MT
May. 07 Medibank Private Posts 3.3% Health Insurance Premium Increase for March; Shares Up 3% MT

Evolution of the average Target Price on Medibank Private Limited

Price target over the last 5 years

History of analyst recommendation changes

e167379bdd47620.7jCYqoRzXagJOwG4OhyxVlAjYP9sQAXQ3Wa0a8ShSNQ.tnT-0O80HJptbXGLVH3bOT1aVYgjJma3jwjxXLXVIe2AW_HfwAQcwWsCMQ~1c22f22e5579d14df89c9774157ff26e

Analyst Recommendations on Medibank Private Limited

Jarden Adjusts Medibank Private Price Target to AU$3.85 from AU$3.80, Keeps at Neutral MT
Morgan Stanley Adjusts Medibank Private’s Price Target to AU$3.84 From AU$3.66, Keeps at Equalweight MT
Jarden Research Downgrades Medibank Private to Neutral From Overweight, Keeps Price Target at AU$3.75 MT
Signals of Further US Fed Rate Hikes Send Australian Shares to Third Day of Losses MT
Australian shares jump after Powell signals slowdown in rate hikes RE
Fitch Ratings Expects Australia to Tighten Laws, Regulation Following Recent Cyberattack Incidents MT
UBS Adjusts Medibank Private's Price Target to AU$4 From AU$3.90, Keeps at Buy MT
UBS Adjusts Medibank Private's Price Target to AU$3.25 From AU$3.5, Keeps at Neutral MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
3.65 AUD
Average target price
3.876 AUD
Spread / Average Target
+6.19%
High Price Target
4.3 AUD
Spread / Highest target
+17.81%
Low Price Target
3.45 AUD
Spread / Lowest Target
-5.48%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Medibank Private Limited

Morgan Stanley
Jarden Research
UBS

Ratings for Medibank Private Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MPL Stock
  4. Consensus Medibank Private Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW